MarketPeel
Insider Trading Intelligence
Pricing
…
MH

Mark Hopman

BBNX
CHIEF COMMERCIAL OFFICER · BETA BIONICS, INC. · CIK 0002048497
FILING MIX · LIFETIME45%/55%
BUYS
15
SELLS
18
TOTAL VALUE
$1.03M
COMPANIES
1
ACTIVE SINCE
Jan 2025
HOLDINGS NOW
129,354
AVG SELL PX
$18.33
TRADE KIND
SHOWING 33 / 33
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 21 pending
Forward-return performance of every backtestable P/S trade by Mark Hopman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+27.27%+8.84%+0.66%+8.18%+2.68%—
14d11+27.27%+5.60%+0.48%+5.12%+2.38%—
30d11+54.55%-2.63%+1.82%-4.45%-2.32%—
60d11+63.64%-2.34%+4.33%-6.67%-17.15%—
90d11+27.27%+10.89%+5.41%+6.86%-8.03%—
180d11(2 pending)+66.67%-4.90%+10.04%+0.03%-18.77%—
1y11(8 pending)+100.00%-31.46%————
2y11(11 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BBNX · 129,354 shares · as of Jun 24, 2026
035,08070,160105,240140,3202026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 18 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BBNX
BETA BIONICS, INC.
SALE10b5-1
10b5-1 plan
1,258$15.01$18.9K129,354Jun 24, 2026Jun 25, 2026 ↗View →
BBNX
BETA BIONICS, INC.
SALE10b5-1
10b5-1 plan
275$12.31$3.4K130,612Jun 4, 2026Jun 5, 2026 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
5,329$12.61$67.2K130,887Jun 2, 2026Jun 3, 2026 ↗View →
BBNX
BETA BIONICS, INC.
SALE10b5-1
10b5-1 plan
353$11.57$4.1K139,133Mar 4, 2026Mar 5, 2026 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
834$12.36$10.3K139,486Mar 2, 2026Mar 3, 2026 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
58,749——58,749Feb 27, 2026Mar 3, 2026 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
109,105——140,320Feb 27, 2026Mar 3, 2026 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
91,520——91,520Feb 27, 2026Mar 13, 2026 ↗View →
BBNX
BETA BIONICS, INC.
SALE10b5-1
10b5-1 plan
2,061$30.66$63.2K136,216Dec 4, 2025Mar 16, 2026 ↗View →
BBNX
BETA BIONICS, INC.
SALE10b5-1
10b5-1 plan
856$29.34$25.1K138,277Dec 2, 2025Mar 16, 2026 ↗View →
BBNX
BETA BIONICS, INC.
SALE10b5-1
10b5-1 plan
11,411$20.56$234.7K31,215Sep 5, 2025Sep 8, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
11,411——21,725Sep 5, 2025Sep 8, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASE
Chief Commercial Officer
11,411$5.10$58.2K42,626Sep 5, 2025Sep 8, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASE
Chief Commercial Officer
656$5.10$3.3K33,940Sep 4, 2025Sep 8, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASE
Chief Commercial Officer
4,093$5.10$20.9K38,033Sep 4, 2025Sep 8, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
4,093——33,136Sep 4, 2025Sep 8, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE10b5-1
10b5-1 plan
6,818$19.97$136.2K31,215Sep 4, 2025Sep 8, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
656——66,428Sep 4, 2025Sep 8, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
848$18.86$16.0K33,284Sep 2, 2025Sep 3, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE10b5-1
10b5-1 plan
16,158$16.61$268.4K34,132Aug 19, 2025Aug 20, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
16,158——67,084Aug 19, 2025Aug 20, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASE
Chief Commercial Officer
16,158$5.10$82.4K50,290Aug 19, 2025Aug 20, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
238$17.03$4.1K34,762Jun 2, 2025Jun 4, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
79$18.69$1.5K34,132Jun 2, 2025Jun 4, 2025 ↗View →
BBNX
BETA BIONICS, INC.
SALE
Chief Commercial Officer
551$18.15$10.0K34,211Jun 2, 2025Jun 4, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
52,000——52,000Feb 27, 2025Mar 3, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Feb 27, 2025Mar 3, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
17,765——17,765Jan 31, 2025Feb 3, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
47,775——47,775Jan 31, 2025Feb 3, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
37,229——37,229Jan 31, 2025Feb 3, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
83,242——83,242Jan 31, 2025Feb 3, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
39,424——39,424Jan 31, 2025Feb 3, 2025 ↗View →
BBNX
BETA BIONICS, INC.
PURCHASEGRANT
Stock grant
47,775——47,775Jan 29, 2025Jan 31, 2025 ↗View →
Other insiders · BBNX
Loading peer insiders…
About this filer
CIK 0002048497
ROLE
Chief Commercial Officer
PRIMARY
BBNX
COMPANIES
1
ACTIVE SINCE
Jan 2025
MARKETPEEL · /INSIDER/0002048497DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback